STO:SUS

Surgical Science Sweden AB (publ) · STO · Healthcare · SEK · FY for 2025

Figures on this page computed 2026-11-08 02:32 UTC

Last close

n/aSEK

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

47.1xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed
- Computed from the filing for 2025
1.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
6.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
6.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
0.02Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

2.30x

0.91x

1.29x

1.65x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales2.30x
Its own average over 10 years, 431.0M.
Profit0.91x
Its own average over 10 years, 73.1M.
Free cash flow1.29x
Its own average over 10 years, 52.8M.
Debt1.65x
Its own average over 10 years, 47.8M.
Pricen/a
Its own average over 0 years. Market data

Sales is furthest from its own average, at 2.30 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2016-12-31	100.0	100.0	100.0
2017-12-31	111.9	-68.4	136.9
2018-12-31	126.8	-136.9	172.3
2019-12-31	196.0	381.8	202.9
2020-12-31	202.3	472.9	240.0
2021-12-31	708.1	2,613.6	298.0
2022-12-31	1,549.3	5,696.2	355.6
2023-12-31	1,704.3	7,090.1	355.7
2024-12-31	1,706.7	3,989.3	356.3
2025-12-31	1,915.7	2,024.8	356.3

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: SEK

How profit was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: SEK

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: SEK

Figures behind the shape

Growth

56.8%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate56.8%
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed
Five-year EPS growth rate23.8%
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed
One-year change in net income-49.2%
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed

Returns on capital

1.9%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital1.9%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity1.6%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets1.4%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

58.1%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin58.1%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin11.0%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin6.7%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin6.9%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

47.1x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings47.1x
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed
- Computed from the filing for 2025
Price to book0.7x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA13.6x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio3.2x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

0.02

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.02
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio4.07
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage17.3x
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score5.24
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
SEK
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.